14.01.2011 • NewsUralkaliBelarusian PotashBPC

Uralkali Exporter to Supply 600,000 Tons of Output to China

Russian potash producer Uralkali said on Thursday its Belarusian Potash Co (BPC) export joint venture will supply 600,000 tons of output to two major Chinese buyers at $400 per ton.

Analysts at Troika Dialog said this was a 14% year-on-year increase.

BPC, the joint venture trader for Uralkali and Belaruskali, controls more than 30% of global exports, and the price hike shows that improved demand is once again allowing it to flex its muscles on the international market.

The contract, which includes cost and freight (CFR), will run from Jan 13 to June 30. Sinochem and CNAMPGC are the buyers. Spot potash prices, which soared above $1,000 per ton before the 2008 downturn, are currently at $430 per ton CFR, according to Troika.

The bank's analysts expect prices to rise further this year.

"We believe that potash producers will pursue measured price increases over 2011 from the current $430/ton CFR to around $500/ton by year end, so it makes sense for China to sign a deal and not procrastinate," they wrote.

This is the first time China has switched to semi-annual contracts.

Uralkali is in the process of merging with domestic rival Silvinit to create the world's number two producer behind Canada's Potash Corp.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.